ACMSD (NP_612199, 179 a.a. ~ 278 a.a) partial recombinant protein with GST tag. The sequence is SHGFSMRPDLCAQDNPMNPKKYLGSFYTDALVHDPLSLKLLTDVIGKDKVILGTDYPFPL GELEPGKLIESMEEFDEETKNKLKAGNALAFLGLERKQFE
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase; EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM, Oct 2004]
Pathway
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA; Metabolism; Tryptophan catabolism; Tryptophan metabolism.
Citations
Publication ()
Have you cited DPAB-DC539 in a publication? Let us know and earn a reward for your research.
My Review for Anti-ACMSD (aa 179-278) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.